Chronic liver diseases (CLDs) are increasing in prevalence and their end-stage complications, namely, cirrhosis, liver failure and hepatocellular carcinoma represent major global challenges. The most common initiators of progressive CLD are viral hepatitis and long-term alcohol abuse as well as steatosis and steatohepatitis. Irrespective of the underlying aetiology, a common feature of CLD is the formation of hepatic ductular reactions, involving the proliferation of liver progenitor cells (LPCs) and their signalling to fibrosis-driving hepatic stellate cells. The Wnt/?-catenin pathway has been found to regulate development, stemness and differentiation, and alterations in its activity have been associated with tumour development. Recent data highlight the role of Wnt/?-catenin signalling in hepatic metabolism, steatosis and cancer, and suggest targeting of this pathway as a promising molecular strategy to potentially inhibit CLD progression and hepatocarcinogenesis.
Details
Title
Wnt/?-Catenin Signalling during Liver Metabolism, Chronic Liver Disease and Hepatocarcinogenesis
Authors/Creators
Gayatri D Shirolkar - Curtin University
Sara Pasic - Curtin University
Jully Gogoi Tiwari
Manoj K Bhat - Savitribai Phule Pune University
John K Olynyk - Edith Cowan University
Arun Dharmarajan - Curtin University
Janina EE Tirnitz-Parker
Publication Details
Journal of renal and hepatic disorders, Vol.2(1), pp.1-9